WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) sponsored legislation filed today to ban the sale, manufacture or possession of any new military-style assault weapons.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) today released the following statement on the president’s decision to declare a national emergency:
The ‘Every Kid in a Park’ program allows fourth-grade students to enter all federally-managed public lands for free
WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO) and Scott Tipton (R-CO) introduced bipartisan legislation today to make permanent an existing national parks program that allows U.S. fourth-grade students, and their families, to visit any federally-managed parks, lands or waters for free for an entire year.
WASHINGTON, D.C. – Just days before the one-year anniversary of the tragic mass-shooting that took place at Marjory Stoneman Douglas High School in Parkland, Florida, a group of federal lawmakers is introducing legislation aimed at preventing another similar attack from occurring elsewhere in the U.S.
The drug is up to ten times more powerful than fentanyl and 1,000 times more powerful than morphine
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) and Sen. Edward J. Markey (D-Mass.) today called on the Food and Drug Administration (FDA) to provide documents related to its approval of Dsuvia, a new formulation of the opioid painkiller sufentanil.
Washington, DC – U.S. Rep. Diana DeGette (D-CO) released the following statement on the president’s State of the Union speech this evening:
Washington, DC – U.S. Rep. Diana DeGette (D-CO), chair of the House oversight panel investigating the Trump administration’s child-separation policy, today announced the full list of witnesses set to testify this week at the committee’s first oversight hearing on the administration’s controversial policy.
Colorado’s Rep. Diana DeGette will chair the panel’s hearing on the controversial policy
Washington, DC. – The chairman of the House oversight panel investigating the Trump administration’s child-separation policy, U.S. Rep. Diana DeGette (D-CO), announced today that her committee will hold its first hearing on the administration’s controversial policy one week from today.
Lawmakers calling on major U.S. pharmaceutical companies to justify price hike
Washington, DC – Two of the top Democrats on the House Energy and Commerce Committee joined forces today in calling on the heads of three major U.S. pharmaceutical companies to explain the recent skyrocketing cost of insulin.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) today joined with several of her House colleagues to introduce legislation that would block the implementation of President Donald Trump’s travel ban policy.